National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy.

Autor:	Zandi PP; From the Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD., Morreale M; From the Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD., Reti IM; From the Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD., Maixner DF; Department of Psychiatry, University of Michigan, Ann Arbor, MI., McDonald WM; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA., Patel PD; Department of Psychiatry, University of Michigan, Ann Arbor, MI., Achtyes E; Division of Psychiatry and Behavioral Medicine, Michigan State University, Grand Rapids, MI., Bhati MT; Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA., Carr BR; Department of Psychiatry, University of Florida Health, Gainsville, FL., Conroy SK; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN., Cristancho M; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA., Dubin MJ; Department of Psychiatry, Weill Cornell Medicine, New York, NY., Francis A; Department of Psychiatry and Behavioral Health, Penn State University, Hershey, PA., Glazer K; From the Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD., Ingram W; Department of Mental Health, Johns Hopkins University, Baltimore, MD., Khurshid K; Department of Psychiatry, UMass Memorial Health Care, Worchester, MA., McClintock SM; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX., Pinjari OF; Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Care Center at Houston, Houston, TX., Reeves K; Department of Psychiatry and Behavioral Health, Ohio State University College of Medicine., Rodriguez NF; Department of Psychiatry, University of Cincinnati College of Medicine, Cincinatti, OH., Sampson S; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN., Seiner SJ; Department of Psychiatry, McLean Hospital, Belmont, MA., Selek S; Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Care Center at Houston, Houston, TX., Sheline Y; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA., Smetana RW; Department of Psychiatry, Weill Cornell Medicine, New York, NY., Soda T; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC., Trapp NT; Department of Psychiatry, Carver College of Medicine, University of Iowa Healthcare, Iowa City, IA., Wright JH; Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY., Husain M; Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX., Weiner RD; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC.
Jazyk:	angličtina
Zdroj:	The journal of ECT [J ECT] 2022 Sep 01; Vol. 38 (3), pp. 159-164. Date of Electronic Publication: 2022 Mar 04.
DOI:	10.1097/YCT.0000000000000840
Abstrakt:	Abstract: Electroconvulsive therapy (ECT) is a highly therapeutic and cost-effective treatment for severe and/or treatment-resistant major depression. However, because of the varied clinical practices, there is a great deal of heterogeneity in how ECT is delivered and documented. This represents both an opportunity to study how differences in implementation influence clinical outcomes and a challenge for carrying out coordinated quality improvement and research efforts across multiple ECT centers. The National Network of Depression Centers, a consortium of 26+ US academic medical centers of excellence providing care for patients with mood disorders, formed a task group with the goals of promoting best clinical practices for the delivery of ECT and to facilitate large-scale, multisite quality improvement and research to advance more effective and safe use of this treatment modality. The National Network of Depression Centers Task Group on ECT set out to define best practices for harmonizing the clinical documentation of ECT across treatment centers to promote clinical interoperability and facilitate a nationwide collaboration that would enable multisite quality improvement and longitudinal research in real-world settings. This article reports on the work of this effort. It focuses on the use of ECT for major depressive disorder, which accounts for the majority of ECT referrals in most countries. However, most of the recommendations on clinical documentation proposed herein will be applicable to the use of ECT for any of its indications. Competing Interests: D.F.M. has received research support for the clinical study of ketamine in depression and past travel expenses for program and research development from the National Network of Depression Centers. He has research support from Janssen at present. He has past research funding from Neuronetics and St. Jude Medical in the past 10 years; Mustafa Husain has received support from the National Institutes of Health (NIH), National Institute of Mental Health (NIMH), National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke, Brain Initiative, and the Stanley Medical Research Institute. He has received industry grant support from Abbott, Cyberonics, Neuronetics, Brainsway, and NeoSync; William M. McDonald is a member of the American Psychiatric Association Council on Research representing electroconvulsive therapy and neuromodulation therapies. He is compensated as the chair of the Data Safety and Monitoring Board (DSBM) for an NIA multicenter study. He is on the Board of Skyland Trail and 3Keys. He is a paid consultant for Signant Health. He has received past funding from the Stanley Foundation, Soterix, Neuronetics, NeoSync, and Cervel Neurotherapeutics. He has an endowed chair funded by the JB Fuqua Foundation. S. Selek received internal funding from the University of Texas Health Science Center at Houston McGovern Medical School, Louis A. Faillace Department of Psychiatry. S.M.M. has received research funding from the NIH and is a consultant for the Pearson Assessment. E.A. has received funding from the NIA. J.H.W. is a consultant or has equity interest at Mindstreet Inc; American Psychiatric Publishing, Inc; Guilford Press; and Simon and Schuster Book Royalties. He has received grant support from the Agency for Healthcare Research and Quality. T.S. has received funding from the NIH and the Foundation of Hope for Research and Treatment of Mental Illness. W.I. has received funding from the NIMH T32 Psychiatric Epidemiology Training Program (T32MH014592-41). I.M.R. was supported by the NIMH (R01 MH121542) and The Jager Family Foundation. P.P.Z., M.M., R.W.S., S.K.C., K.R., B.R.C., S.J.S., P.D.P., R.D.W., N.F.R., M.T.B., M.C., K.G., A.F., N.T.T., O.F.P., M.J.D., K.K., S. Sampson, and Y.S. have no conflicts of interest or financial disclosures to report. (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu